INNOVENT BIO Shares Slide on Founder's Share Sale

Stock News05-15 10:36

INNOVENT BIO (01801) saw its shares drop more than 8% in early trading. At the time of writing, the stock was down 7.61% to HK$80.1, with a turnover of HK$845 million. The decline follows news that the company's founder, Chairman, and CEO, Dechao Yu, sold 1.353 million shares on May 11, 2026, at an average price of HK$89.362 per share, raising approximately HK$121 million. Following this transaction, his shareholding decreased to 7.49%, though he remains the largest single shareholder. China Post Securities noted that INNOVENT BIO achieved its first full-year profit in 2025, signaling that its business model has proven successful and the company has officially entered a profitable era. The gross profit margin benefited from economies of scale and improved production efficiency, increasing by 2.3 percentage points year-over-year to 87.2%. Revenue growth was robust, while the sales and administrative expense ratio decreased by 2.9 percentage points year-over-year to 48.0%. EBITDA surged 384% year-over-year to RMB 1.99 billion. Cash and cash equivalents stood at RMB 24.3 billion, equivalent to approximately US$3.5 billion, providing a solid foundation for long-term development.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment